We have already completed one research project Rapid Assessment of Avoidable Blindness in tribal areas of Surat District along with the Willingness to Pay component and the presentation of its findings has won an award at the Gujarat State Conference also. The same has been presented at many for a including AIOS, IAPB, ISGEO etc.
Analysis for three more studies is going on Comprehensive door to door survey of blindness in Mandvi taluka, socio economic status of the community in Mandvi taluka and door to door screening for diabetes using blood sugar examination for 40+ populations in Mandvi taluka. Once we are ready with analysis, we will publish this data also.
One more study of Rapid Assessment of Visual Impairment in Surat district was completed and the results were presented at the American Academy of Ophthalmology conference at Chicago last year. This study is supported by Sir Dorabjee Tata Trust Mumbai.
Our hospital was also one of center for a multicentre study titled The emerging epidemic of diabetic retinopathy (DR) in India: Situation analysis and evaluation of existing programmes for screening and treatment for DR conducted by International Center for Eye Health (ICEH), London and Indian Institute of Public Health- Public Health foundation of India (IIPH-PHFI), Hyderabad.
We participated in a multicenter study of Spectrum of Eye Disease in Diabetes SPEED study conducted at 14 centers across the country. The study was commissioned by Public Health Foundation of India, Hyderabad.
Couple of clinical studies one on efficacy of Avastin in treatment of CRVO and the other on trends of glaucoma in rural areas of Surat district were conducted and presented in conferences.
We plan to conduct many more clinical and epidemiological studies in future. A team is being created for research activities. One such Prospective study of outcome of SICS a comparison of experienced and fresh surgeon's outcome is started recently.
One more study of Community Screening for Diabetes, Blood Pressure, Intraocular Pressure and Fundus photography is going on. The data collection will be completed by the end of April 2017.
We have our own registered Institutional Ethics Committee to give clearance to conduct trails.
Currently we engage in following clinical trials:
1. The study titled An open-label, single-arm clinical study to evaluate efficacy, safety and tolerability of tacrolimus lipid suspension for ophthalmic drops in adult patients of allergic conjunctivitis refractory to standard treatment Sponsor by LAMBDA.
2. The study titled A Double Masked, Parallel Group, Randomized, Multicenter, Clinical Study to Compare Efficacy and Safety of Intas Ranibizumab with Lucentis in Patients with Neovascular (Wet) Age-Related Macular Degeneration (AMD) Sponsor by LAMBDA.
3. A randomized, open label, single center study to assess the safety and efficacy of Ultraviolet-C rays (4mJ/cm2) plus Methylene Blue eye drops (0.03%) vs standard treatment with antimicrobial drops in treatment of infectious keratitis. Self Sponsor
4. Study to evaluate safety and performance of hydrophobic, hydrophilic and PMMA Intraocular Lenses Sponsor by Sharpedge.
5. EUP-OML-21-005: Toric IOL PMCF Study: Prospective, open-label, single-arm, multicentre, observational, post-marketing clinical study to evaluate safety and performance of Toric hydrophilic Acrylic Intraocular Lens (IOL) (Omni Lens Pvt. Ltd.) in patients who require IOL implantation during routine cataract surgery by Dr. Nilesh Naik Principal Investigator.
6. EUP-OML-21-006: Multifocal IOL PMCF Study: Prospective, open-label, single-arm, multicentre, observational, post-marketing clinical study to evaluate safety and performance of multifocal hydrophobic acrylic foldable intraocular lens (IOL) (Omni Lens Pvt. Ltd.) in patients who require IOL implantation during routine cataract surgery by Dr. Uma Shroff Principal Investigator.
7. Study Title: A randomized, double - blind and multicenter study to compare the efficacy and safety of topical Forskolin (0.15%) and topical Timolol (0.5%) in patients with ocular hypertension or open angle glaucoma.
8. A Comparison of the effectiveness of strabismic amblyopia treatment with eye-patch and binocular occlu-tab for home training Submitted by Dr. Anshulee Sood (Consultant, pediatric ophthalmology and strabismus), Dr. Uma Shroff (Consultant, pediatric ophthalmology and strabismus) and Dr. Uday gajiwala (Superintendent and head, Tejas eye hospital, Mandvi, Surat, gujarat, India.)